查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1138306

全球醫用特種袋市場-2022-2029

Global Medical Specialty Bags Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

全球醫療專用袋市場的增長受到某些因素的推動，例如造口術等外科手術的增加。結腸癌、憩室炎和 IBD 等幾種疾病的發病率不斷上升，推動對外科手術的需求是推動市場增長的關鍵因素之一。

預計外科手術的增加將在預測期內推動全球醫療專用袋市場。

手術涉及大量出血，需要輸血，所以用於血液及血液成分運輸、腎透析、採集、處理、儲存等的專用醫用袋的採用率很高。我是這裡。因此，在預測期內，增加手術、透析和輸血程序預計將推動市場增長。

不斷增長的老年人口是尿失禁發病率增加的主要因素之一，預計將推動對尿液收集袋的需求。由於老年人容易出現尿失禁，對醫療專用袋的需求正在增加。根據疾病控制和預防中心 (CDC) 的數據，慢性腎髒病 (CKD) 在 65 歲以上的人群中 (38%) 比在 45-64 歲 (13%) 和 18-44 歲 (7 %）。由於人口結構的持續變化，一些國家正面臨挑戰。根據聯合國經濟和社會事務部人口司的數據，2017 年，世界 60 歲人口預計在未來 30 年內翻一番，而 80 歲人口預計將增加兩倍。

此外，由於醫療保健領域技術的進步和醫療設施的擴大，預計醫療專用袋市場將在預測期內顯著增長。衛生和健康意識的提高正在推動醫療專用袋市場的增長。此外，政府組織增加支持將對市場增長產生積極影響，因為它將鼓勵對醫療基礎設施的投資、有利的報銷政策以及鼓勵研發活動。

COVID-19 影響分析

隨著 COVID-19 的爆發，實驗室正在加緊研發，以尋找可以及早減輕冠狀病毒症狀的解決方案。已確定靜脈注射免疫球蛋白和 LMWH（低分子量肝素）抗凝劑有望改善 COVID-19 的預後。因此，輸液袋和其他醫療專用袋市場的公司已經註意到了這一趨勢，並正在努力在 COVID-19 爆發期間提高其生產能力。靜脈注射免疫球蛋白治療和LMWH抗凝可減少外周血淋巴細胞和B淋巴細胞，從而改善患者。在 COVID-19 患者中啟動靜脈注射免疫球蛋白和 LMWH 抗凝劑預計將為特種醫療袋製造商創造收入機會。然而，由於 COVID-19，原材料供應和供應延遲是包裝製造商目前在市場上面臨的一些挑戰。

行業分析

全球醫用特種袋市場基於波特五力分析、供應鏈分析、監管分析、價格分析、流行病學、管道分析、未滿足需求等各種行業因素提供分析。

全球醫療專用袋市場報告提供了大約 40 多個市場數據表、45 多個數字和 180 頁的結構。

內容

第1章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按產品劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
  • 驅動程序
    • 增加手術、透析和輸血程序
    • 易患尿失禁的老年人增多
  • 限制因素
    • 缺乏保險報銷
  • 商機
  • 影響分析

第5章行業分析

  • 波特五力分析
  • 流行病學
  • 管道分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 未滿足的需求

第 6 章按產品分類

  • 尿袋
  • 持續不臥床腹膜透析 (CAPD) 袋
  • 麻醉用呼吸袋
  • 血袋
  • 造口用尿液收集袋
    • 一次性袋子
    • 多用袋
  • 腸內營養袋
  • 膽汁收集袋
  • 無菌包裝袋
  • 復甦包
    • 一次性袋子
    • 可重複使用的袋子
  • 滴水袋
    • PVC袋
    • 非氯乙烯輸液袋
  • 屍袋
  • 灌腸袋
  • 冰袋

第 7 章最終用戶的構成比

  • 醫院
  • 手術中心
  • 保健中心
  • 家庭保健
  • 其他

第 8 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 9 章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第 10 章公司簡介

  • B.Braun Melsungen AG
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Baxter International Inc.
  • Coloplast AS
  • ConvaTec Group Plc
  • Hollister Inc.
  • Becton, Dickinson, and Co.
  • Cardinal Health Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Terumo Corporation
  • Kawasumi Laboratories Inc（List Not Exhaustive）

第11章 DataM

簡介目錄
Product Code: DMHOS2611

Market Overview

Medical specialty bags market size was valued at US$ 10.44 billion in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 4.9% during the forecast period (2022-2029).

Medical specialty bags are used in various applications such as urine collection, blood storage, bile collection, enteral feeding, sterile packaging, among others. These collection bags are manufactured with advanced materials to enhance their quality and are used to avoid any contamination. These medical specialty bags are highly used in hospitals to prevent the risk of any disease or infection. The rising demand for aseptic conditions in the medical institutes has increased the popularity of medical specialty bags globally.

Market Dynamics

The global medical specialty bags market growth driven by certain factors such as by increasing surgical procedures, such as ostomy procedures. The increasing incidence of several disorders such as colorectal cancer, diverticulitis, and IBD is driving the demand for surgical procedures are among the key factors driving the market growth.

Increasing surgical procedures, is expected to drive the global medical specialty bags market during the forecast period

The surgical procedures involve a lot of blood loss, and there is a need for blood transfusions, which is leading to higher adoption of medical specialty bags as these are used for the transfer of blood and blood components, renal dialysis and collection, processing, and storage. Therefore, the increasing number of surgical procedures, dialysis, and blood transfusion procedures are expected to stimulate market growth over the forecast period.

The growing geriatric population is one of the major factors responsible for the increase in incidences of urinary incontinence which is expected to drive the demand for urinary collection bags. Since the aged population is more prone to urinary incontinence, the demand for medical specialty bags is increasing. Chronic kidney disease (CKD) is more common in people aged 65 years or older (38%) than in people aged 45-64 years (13%) or 18-44 years (7%) according to Centers for Disease Control and Prevention (CDC). Several countries are facing challenges due to the ongoing and increasing demographic shift in age among their people. According to the Department of Economic and Social Affairs Population Division of United Nations, 2017, the world's population who are 60 years old will double and those of 80 years old will triple during the next 30 years.

Furthermore, the medical specialty bags market is expected to grow significantly over the forecast period due to the increasing technological advancements in the healthcare sector and improved medical facilities. The increasing awareness of hygiene and health is fuelling the growth of the medical specialty bags market. Also, growing support from government organizations positively affects market growth since they facilitate investments in the healthcare infrastructure, favorable reimbursement policies, and encouraging research and development activities.

COVID-19 Impact Analysis

Due to the outbreak of COVID-19, research labs have increased their research & development to find solutions that can minimize the symptoms of coronavirus at early stages. It is observed that the intravenous immunoglobulin and LMWH (Low-molecular-weight heparin) anticoagulant therapy holds promising potentials in improving the COVID-19 prognosis. Hence, companies in the IV bags and other medical specialty bags market are focusing on this trend and increasing their efforts to boost the production capabilities amidst the COVID-19 pandemic. Intravenous immunoglobulin and LMWH anticoagulant therapy can lower the lymphocytes and B lymphocytes in peripheral blood, resulting in improvements in patients. The initiation of IV immunoglobulin and LMWH anticoagulant therapy in COVID-19 patients is projected to create revenue opportunities for manufacturers of medical specialty bags. However, lack of raw material availability and delayed supplies are some of the challenges that packaging manufacturers are currently facing in the market due to COVID-19.

Industry Analysis

The global medical specialty bags market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis, epidemiology, pipeline analysis, unmet needs.

Segment Analysis

The ostomy collection bags segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

Based on product, the global medical specialty bags market is segmented into urinary collection bags, continuous ambulatory peritoneal dialysis (CAPD) bags, anesthesia breathing bags, blood bags, ostomy collection bags, enteral feeding bags, bile collection bags, sterile packaging bags, resuscitation bags, intravenous fluid bags, cadaver bags, enema bags, and ice bags. Among these, the ostomy collection bags is estimated to dominated the global medical specialty bags market during the forecast period. These are available in either single-use bags or multiple-use bags. The SenSura Mio Baby ostomy bag manufactured by Coloplast is characterized by its long wear time, which ensures that premature babies are not disturbed. The bag adhesive is designed for sensitive skin and easy reuse. It stays on the baby's belly when the bag is changed. The SenSura Mio Kids ostomy bag is covered in a skin-friendly textile and discreet under clothing.

The Intravenous fluid bags are estimated to grow at the fastest growth rate over the forecast period, due to their various applications such as maintaining the correct electrolyte imbalance, sustaining and balancing the basal hydration level, and expanding IV volumes hypovolemic state in patients. Also, IV fluid bags are used in various healthcare processes along with the convenience and ease with to provide nutrition to any patient. However, the IV bags market is expected to experience a few challenges owing to the consequences of sterilizing IV bags. Also, with growing environmental impacts associated with the use of PVC, demand is anticipated to shift towards non-PVC material over the forecast period.

The IV bags market is predicted to reach an output of over 5,000 units by the end of 2027. However, a shortage of IV fluids in the U.S. healthcare system is likely to hamper the market for IV bags. Hence, pharmaceutical companies are adopting several strategies to strengthen their supply chains in the U.S. For instance, B. Braun has launched its Solutions for Life initiative by investing in IV therapy manufacturing facilities to ensure long-term supplies for the U.S. healthcare systems. Such initiatives are helpful for companies in the IV bags market.

Geographical Analysis

North America region holds the largest market share of the global medical specialty bags market

North America region is dominating the global Medical Specialty Bags market accounted for the largest market share in 2021, owing to rising incidences of chronic disorders and increasing surgical procedures which increases the demand for medical specialty bags. As per the National Association for Incontinence (NAFC), in North America, nearly 200 million people are affected by urinary incontinence. The United States and Canada are the key contributing regions for medical specialty bags in North America, owing to well-established healthcare infrastructure and favorable reimbursement policies in these countries.

Competitive Landscape

The medical specialty bags market is highly competitive and consists of several major players and the emergence of new players in the market. Some of the key players which are contributing to the growth of the market are B. Braun Melsungen AG, Baxter International Inc., Coloplast AS, ConvaTec Group Plc, Hollister Inc., Becton, Dickinson and Co., Cardinal Health Inc., Fresenius Medical Care AG & Co. KGaA, Terumo Corporation, Kawasumi Laboratories Inc, among others.

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the medical specialty bags market globally. For instance, in May 2019, B. Braun Medical has announced that it is investing $1 billion into new and existing IV fluid manufacturing facilities to address the IV solution shortage exacerbated by Hurricane Maria's making landfall in Puerto Rico.

Key Companies to Watch

B. Braun Melsungen AG

Overview: B. Braun is a German manufacturer of medical and pharmaceutical devices. The B. Braun product line includes 5,000 items, 95 percent of which are manufactured by the company. The company's product portfolio includes infusion, nutrition, and pain therapy products, as well as infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, and ostomy, disinfection, and wound care products.

Product Portfolio: Flexima Uro Silk Flat Urostomy Bags- The Flexima Uro Silk convex urostomy bags are designed for people with flush or slightly retracted urostoma.

The global medical specialty bags market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market snippet by End-User
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. Rising surgical, dialysis, and blood transfusion procedures
    • 4.2.2. Growing geriatric population prone to urinary incontinence
  • 4.3. Restraints:
    • 4.3.1. Lack of reimbursement
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Epidemiology
  • 5.3. Pipeline Analysis
  • 5.4. Supply Chain Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Unmet Needs

6. By Product

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
    • 6.1.2. Market Attractiveness Index, By Product Segment
  • 6.2. Urinary Collection Bags*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 6.3. Continuous ambulatory peritoneal dialysis (CAPD) bags
  • 6.4. Anesthesia breathing bags
  • 6.5. Blood bags
  • 6.6. Ostomy collection bags
    • 6.6.1. Single-use bags
    • 6.6.2. Multiple-use bags
  • 6.7. Enteral feeding bags
  • 6.8. Bile collection bags
  • 6.9. Sterile packaging bags
  • 6.10. Resuscitation bags
    • 6.10.1. Disposable bags
    • 6.10.2. Reusable bags
  • 6.11. Intravenous (IV) fluid bags
    • 6.11.1. PVC material based fluid bags
    • 6.11.2. Non- PVC material based fluid bags
  • 6.12. Cadaver bags
  • 6.13. Enema bags
  • 6.14. Ice bags

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
    • 7.1.2. Market Attractiveness Index, By End-User Segment
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 7.3. Surgical Centers
  • 7.4. Healthcare centers
  • 7.5. Home Healthcare
  • 7.6. Others

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. The U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Germany
      • 8.3.5.2. The U.K.
      • 8.3.5.3. France
      • 8.3.5.4. Italy
      • 8.3.5.5. Spain
      • 8.3.5.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Brazil
      • 8.4.5.2. Argentina
      • 8.4.5.3. Rest of South America
  • 8.5. Asia Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. China
      • 8.5.5.2. India
      • 8.5.5.3. Japan
      • 8.5.5.4. Australia
      • 8.5.5.5. Rest of Asia Pacific
  • 8.6. The Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

  • 10.1. B. Braun Melsungen AG*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. Baxter International Inc.
  • 10.3. Coloplast AS
  • 10.4. ConvaTec Group Plc
  • 10.5. Hollister Inc.
  • 10.6. Becton, Dickinson, and Co.
  • 10.7. Cardinal Health Inc.
  • 10.8. Fresenius Medical Care AG & Co. KGaA
  • 10.9. Terumo Corporation
  • 10.10. Kawasumi Laboratories Inc (List Not Exhaustive)

11. DataM Intelligence

  • 11.1. Appendix
  • 11.2. About Us and Services
  • 11.3. Contact Us